Company profile: Afyren
1.1 - Company Overview
Company description
- Provider of biotechnological and green chemistry solutions that valorize non-food biomass into biosourced molecules and natural organic acids. Offers AFYREN NEOXY production facility, FLAVYREN flavor and fragrance acids with a low carbon footprint, and a circular eco approach using organic waste and aiming for zero industrial waste via by-product valorization.
Products and services
- Biotechnological approach: custom-engineered bioprocess using natural microbial communities to produce biosourced molecules from non-food biomass, valorizing organic material waste while respecting environmental constraints
- AFYREN NEOXY: industrial-grade facility utilizing AFYREN’s technology to produce seven natural organic acids, constructing natural, biosourced chemical products at scale
- FLAVYREN: range of seven natural organic acids for flavor and fragrance ingredients, produced with a low carbon footprint, supplying biosourced molecules
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Afyren
Accuri Cytometers
HQ: United States
Website
- Description: Provider of cost-effective flow cytometers for laboratory use, designed to deliver rapid cell-by-cell analysis while reducing barriers for researchers, including instrument cost, software complexity, and maintenance effort.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accuri Cytometers company profile →
Neothetics
HQ: United States
Website
- Description: Provider of clinical-stage specialty pharmaceutical therapeutics for the aesthetic market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neothetics company profile →
SeraCare Life Sciences
HQ: United States
Website
- Description: Provider of products and services facilitating R&D and production of human and animal diagnostics and therapeutics, including diagnostic controls, plasma-derived reagents, molecular biomarkers, biobanking, clinical genomics NGS reference standards, infectious disease assay tools, immunoassay reagents, OEM biological materials for assay developers, NGS cancer profiling controls, and purified human blood fractions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeraCare Life Sciences company profile →
Arima Genomics
HQ: United States
Website
- Description: Provider of 3D genomics solutions including Arima-HiC to capture chromatin organization, Arima Capture-HiC for high-resolution targeted chromatin conformation, and Arima-HiChIP for protein-DNA interaction analysis; plus genome assembly of reference-quality, chromosome-spanning assemblies, and cancer genomics and human health offerings delivering insights into disease mechanisms, biomarkers, and therapeutic targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arima Genomics company profile →
Cellink
HQ: Sweden
Website
- Description: Provider of bench-top bioprinters optimized for the bioprinting of human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellink company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Afyren
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Afyren
2.2 - Growth funds investing in similar companies to Afyren
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Afyren
4.2 - Public trading comparable groups for Afyren
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →